See key changes for the Merit-Based Incentive Payment System for the 2024 performance year as outlined in the proposed rule.
Search results for: opioid
The Rheumatologist Honored with 2 Awards of Excellence
We are honored to announce that The Rheumatologist has received two Awards of Excellence from APEX 2023 for content published in calendar year 2022: an Award of Excellence in the category of Public Health Concerns—Health & Medical for the editorial supplement to the April issue, COVID-19: What We Know, and an Award of Excellence for…
FDA Commissioner Charts Potential & Challenges of Emerging Technologies in Patient Care
Disparities, representativeness, algorithmic bias, the disruptive emergence of large language models and continued misinformation spread are key issues poised to transform patient care in American healthcare, FDA Commissioner Robert M. Califf, MD, said during a recent event.
Drug Enforcement Agency Outlines New Training Requirements
Starting in June, all prescribers registered with the Drug Enforcement Agency must complete a one-time, eight-hour training on treating and managing patients with opioid or substance use disorders.
Gout Research at a Glance
PHILADELPHIA—Approximately 60 research abstracts on gout were accepted for presentation at ACR Convergence 2022, including two plenary abstract presentations. It is exciting to see a wealth of research on gout being undertaken worldwide. Here, we highlight important points from seven of these studies. 1. Abstract 1810: Frequency and Patterns of Opioid Use in the Management…
3 AC&R Study Summaries: MoCA Screening in SLE, Pediatric Social Disadvantages & Surgical Weight Loss Interventions
MoCA as a Screening Test in SLE Assessing the utility of the Montreal Cognitive Assessment (MoCA) By Oshrat E. Tayer-Shifman, MD, Kimberley Yuen, BSc, MD, & Zahi Touma, MD, PhD, FACP, FACR Why was this study done? Cognitive impairment is a common manifestation of systemic lupus erythematosus (SLE), with a prevalence of 40% based on…
Late Summer 2022’s Awards, Appointments & Announcements in Rheumatology
Charles G. Helmick III, MD, Retires After 42 Years with the CDC On Dec. 31, 2021, after 42 years of service, Charles (Chad) G. Helmick III, MD (Capt., USPHS, Ret.), officially retired from the Centers for Disease Control and Prevention. He joined the CDC in 1979, when Jimmy Carter was president, and served through eight…
Some Cannabis Products May Ease Chronic Pain, But Side Effects Are a Concern
NEW YORK (Reuters Health)—Oral synthetic cannabis products that have a high tetrahydrocannabinol (THC) to cannabidiol (CBD) ratio, as well as extracted cannabis products with comparable THC-to-CBD ratios, may provide moderate, short-term improvements in chronic pain, a large systematic review of relevant research suggests.1 However, these products are also associated with higher risks for side effects,…
How Our Thinking Impacts Our Judgment
Let’s start with a couple of short riddles: What question can you never answer “yes” to? Which word does not belong in the following list: stop cop mop chop prop or crop? [The answers appear at the end of this article.] Riddles are designed to make us think beyond the obvious answer. There is usually…
Healthcare Accessibility for People with Rheumatic Disease in New Haven, CT
The COVID-19 pandemic exacerbated wide disparities that exist in the U.S. healthcare system. During the pandemic, the clinical practice in the Section of Rheumatology, Allergy & Immunology at Yale School of Medicine (YSM), New Haven, Conn., rapidly pivoted from face-to-face visits to telehealth to keep our patients and providers safe. Many patients quickly adapted and…
- « Previous Page
- 1
- …
- 9
- 10
- 11
- 12
- 13
- …
- 32
- Next Page »